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Objectives: The aim of this study was to quantitatively assess changes in collagen
structure using MR T1- and T2*-mapping in a novel controlled ex vivo tendon
model setup.
Materials andMethods: Twenty-four cadaveric bovine flexor tendons underwent
MRI at 3 T before and after chemical modifications, representing mechanical de-
generation and augmentation. Collagen degradation (COL), augmenting collagen
fiber cross-linking (CXL), and a control (phosphate-buffered saline [PBS]) were
examined in experimental groups, using histopathology as standard of reference.
Variable echo-time and variable-flip angle gradient-echo sequences were used for
T2*- and T1-mapping, respectively. Standard T1- and T2-weighted spin-echo se-
quences were acquired for visual assessment of tendon texture. Tendons were
assessed subsequently for their biomechanical properties and compared with quan-
titative MRI analysis.
Results: T1- and T2*-mapping was feasible and repeatable for untreated (mean,
545milliseconds, 2.0 milliseconds) and treated tendons.Mean T1 and T2* values
of COL, CXL, and PBS tendons were 1459, 934, and 1017milliseconds, and 5.5,
3.6, and 2.5 milliseconds, respectively. T2* values were significantly different be-
tween enzymatically degraded tendons, cross-linked tendons, and controls, and
were significantly correlated with mechanical tendon properties (r = −0.74,
P < 0.01). T1 values and visual assessment could not differentiate CXL from
PBS tendons. Photo-spectroscopy showed increased autofluorescence of cross-
linked tendons, whereas histopathology verified degenerative lesions of enzymat-
ically degraded tendons.
Conclusions: T2*-mapping has the potential to detect and quantify subtle
changes in tendon collagen structure not visible on conventional clinical MRI.
Tendon T2* values might serve as a biomarker for biochemical alterations asso-
ciated with tendon pathology.
Key Words: bovine flexor tendon, magnetic resonance imaging, T1-mapping,
T2*-mapping, biomechanics, tendinopathy
(Invest Radiol 2018;00: 00–00)
T he Achilles tendon and its enthesis (attachment at the bone) enablethe mechanical force transmission from the calf muscles to the heel
and are therefore important biomechanical structures for plantar flexion
of the foot. The major component of tendon dry weight is collagen type
I (65%–87%), embedded in a noncollagen extracellular matrix that mainly
consists of water and small leucine-rich proteoglycans with glycosaminogly-
can (GAG) side chains.1,2 This extracellular matrix undergoes increasing dis-
organization with advancing stages of tendon disease, with concomitant loss
of mechanical integrity3–6 and change in water permeability.
Magnetic resonance imaging (MRI) is commonly used for
assessing tendon disease based on qualitative morphologic criteria,
but interrater reliability varies substantially ranging from moderate to
excellent.7–9 Moreover, sensitivity of standard turbo spin-echo T1- and
T2-weighted sequences for early tendon degeneration is limited by the
short T2 MR characteristics by highly organized tendon tissue compo-
nents. Because tendons have a characteristically short T2 signal, use of
standard MR sequences results in poorly visualized tendon structures in
both healthy and slightly degenerated Achilles tendon.10
With ultrashort echo-times pulse sequences, it is possible to gain
signal from tissues characterized by a short T2 time (such as tendons)
before complete signal decay.11,12 Alternatively, manipulated variable
echo-time sequences have been shown to be useful for visualization
and quantitative assessment of fast-relaxing tissues, providing high im-
age quality at 3 T and T2*-mapping with very-short echo-times below
1 millisecond.13–16 The short T2* component of the tendon is thought
to represent water protons bound to macromolecules such as GAGs,
whereas the long T2* component is associated with the free water content
of the tendon.17 During tendon cross-linking, which is associated with ten-
don aging and early tendon degeneration,11 changes in tendon structure
lead to a shift from free tomacromolecule boundwater molecules, whereas
proceeding tendon degeneration leads to collagen disruption and an in-
crease of the free water content. The relation of bound versus free water
protons associated with different tendon collagen structures18 might be de-
tected and quantified by T2*-mapping of short echo-times17 and might
therefore serve as a biomarker for collagen degradation.19
Detection of changes within pathological tendons in the absence
of early morphological changes on standard imaging could plausibly pro-
vide clinical benefit, for instance, in the prescription of prophylactic
physiotherapy to mitigate disease progression before the onset of deeper
structural damage.20
The aim of the present study was to implement a phantommodel
for quantitative assessment of changes in tendon structure and mechani-
cal function. Ultimately our goalwas to quantitatively assess the potential
for reliably detecting changes in the physical collagen matrix of tendon
tissue using T1- and T2*-mapping. We tested this using healthy, enzy-
matically degraded and augmented bovine flexor tendons, placing the
MRmeasurements in context of histological and mechanical changes in-
duced by the tissue alteration.
MATERIALS AND METHODS
Study Design
Three experimental groups, each with 8 tendons, were investigated
by MRI. The experiment was performed at 2 different time-points (Fig. 1).
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Half of all tendons were assessed by destructive biomechanical testing,
and the other half were processed for histological analysis.
To obtain a reproducible model with variable mechanical properties
of a tendon, which reflect degenerative changes in the diseased collagen
matrix, we targeted the mechanical properties of the tendon with bio-
chemical substances. It is well known that collagen cross-linking agents
affect the tendon's elastic (ie, elastic modulus) and viscoelastic (ie, stress-
relaxation) behavior,3,21 and elevated tissue cross-linking has been increas-
ingly associatedwith tendon scarring, diabetic tendinopathy, and inflamma-
tory connective tissue disease.22 A denser collagen interconnection,
induced by cross-linking, also results in a decreased matrix porosity, which
consequently will result in reduced water movement. Correspondingly col-
lagenase treatment tends to increase porosity and results in less constrained
tissuewater movement. Collagenase also affects the tendon's elastic behav-
ior23 and leads to a degenerated tendon tissue in a concentration- and time-
dependent fashion by disrupting their collagen continuity.
After an initial image acquisition of yet untreated specimens,
0.2 mL of different solutions were injected with a 24-gauge cannula
or gauge needle directly in the middle portion of the respective tendon.
In the control group, phosphate-buffered saline (PBS) was injected. For
the 2 interventional groups, either collagenase B (COL; 0.226 U/mg
lyo; PBS with Ca2+) with a concentration of 12 mg/mL or a collagen
cross-linking (CXL) solution (2 mL, 80 mM genipin in PBS and 2%
DMSO) with a concentration of 80 mM was infiltrated.
After a second scanning run, the MRI clamping device was then
stored at 37°C in an incubator after wrapping all tendons in saline-
soaked gauzes and sealing them tightly to prevent dehydration. After
24 hours, tendons were then scanned again.
Immediately after the final scan, tendons were removed from the
clamping device and either analyzed biomechanically or histologically
to assess the effects of the imposed chemical treatment.
Phantoms
For this study, 12 bovine flexor tendons with an average cross-
sectional area of 20 mm2 were obtained freshly from a local abattoir
(Metzgerei Angst, Zurich, Switzerland). Immediately after purchase,
the tendonswere prepared by removing synovial lining and unnecessary
soft tissue. Tendons were cut in half (8 cm) and randomly assigned into
3 groups while they were covered in saline-soaked gauze to avoid sam-
ple dehydration. To ensure a reproducible testing environment, tendon
specimens were mounted on a 3-dimensional printed custom-made
MRI compatible clamping device, placed in a plastic container and
filled with PBS. The container was then sealed airtight with its lid
and positioned horizontally into the detector reel, so that tendons were
oriented perpendicular to the axis of the main magnetic field (Fig. 2).
Magnetic Resonance Imaging
Magnetic resonance imaging was performed on a 3 T MRI sys-
tem (MAGNETOM Skyra; Siemens Healthcare, Erlangen, Germany)
using a dedicated knee coil. The MRI study protocol consisted of the
standard clinical MRI protocol at our department for the examination
of the Achilles tendon as well as T1- and T2*-mapping sequences,
which were optimized for imaging of tissues exhibiting short T2* values.
Avariable flip-angle gradient-echo sequence using short radiofrequency
excitation pulses and short echo-times was used for T1-mapping. For
T2*-mapping, a variable echo-time sequence13,14 consisting of a series
of 4 multiecho gradient-echo acquisitions each collecting 5 echo images.
For the complete multiecho acquisition, the first echo timewas variable14
and the 5 echo-train was sequentially shifted to obtain a series of 20 gra-
dient echo images with an echo spacing of 1 millisecond. The imaging
protocol and corresponding imaging parameters are displayed in Table 1.
MRI Data Analysis
T1 values were calculated by the software of the MR system by
pixel-wise fitting of the signal intensities obtained at different flip angles
to the signal equation of a spoiled gradient echo sequence. T2*-map cal-
culationwas performed inMatlab (TheMathWorks Inc, Natick,MA), as-
suming a monoexponential decay of the measured signal intensity S(TE).
T1 and T2* isotropic maps were reformatted in the transverse
plane with a slice thickness of 10-mm centered on the injection site at
the middle of the tendons (Fig. 3). Two independent readers (one
FIGURE 1. Flowchart of the 2 experiments with each 3 groups (collagenase [COL], collagen cross-linked [CXL], or phosphate-buffered saline [PBS]).
Although biomechanical properties were investigated during experiment I, test-retest reliability of the setup, histophatology, and fluorescence
spectroscopy were performed in experiment II. MRI scan t0 is the initial scan and t24 the scan after 1 day of incubation of samples. To asses reproducibility
of the scans using this setup, experiments I and II were performed between 4 weeks' time difference.
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musculoskeletal radiologist with 6 years of experience, one MRI phys-
icist with 10 years of experience) evaluated the images. Image analysis
was fully blinded with respect to specimen grouping, as was analysis of
biomechanical test results, and histopathological grading. Imaging
datasets were evaluated using T1-mapping and T2*-mapping images
with designated ROI implemented freehand along the transverse plane
of each tendon and spanning the maximum tendon diameter but
avoiding the interface between tendon and surrounding water.
T1 and T2* times were assessed separately for untreated and
treated tendons and corresponding percentage differences (Δ) of T1
and T2* times were calculated between matched treated and untreated
tendons according to the following algorithm: ΔT1/T2* = (treated − un-
treated)/untreated  100 (%).
As T1 and T2* values and scaling differ in absolute numbers,
percentage difference were calculated to better compare relative differ-
ence each treatment induced compared with the untreated tendons.
Qualitative Analysis of MRI Data
Two musculoskeletal radiologists (each 6 years of experience),
who were blinded to the test condition and all other results, performed
standard qualitative clinical analysis. Quality of the bovine tendonwas vi-
sually assessed before and after treatment using standard T1-weighted
and STIR (short tau inversion recovery) images in the coronal plane ac-
cording to the clinically implemented protocol of the institution.
In this musculoskeletal imaging center, STIR images are imple-
mented in clinical routine for T2-weighted fat suppression to achieve
more homogeneous fat suppression.
All images were interpreted on a standard workstation using an
integrated picture archiving and communication system (IMPAX 6,
Agfa HealthCare, Bonn, Germany).
Quality of the bovine tendon was rated on a 4-point scale with
the following specifications: 0, “normal tendon,” no T1-/STIR signal
alterations; I, “edema,” hyperintense areas on T1-weighted images; II,
“partial tear,” hyperintense on STIR-weighted images; and III, “com-
plete tear,” discontinuity of the tendon.
Biomechanical Testing of Tendons
For experiment I, all 12 tendons were tested before and after in-
cubation in a calibrated and certified uniaxial universal material testing
machine (Zwick 1456; Zwick GmbH, Ulm, Germany). After applying a
preload of 10N, tendonswere stretched to a strain of 5% and the exerted
FIGURE 2. Experimental setup: custom-made clamping device with 12 tendon samples rigidly mounted in a plastic box (6 up, 6 down), filled with PBS
solution during scans. Collagenase (COL), a cross-linking agent (CXL), or phosphate-buffered saline (PBS) was injected in the tendons to obtain 2
groups undergoing a chemical change in tendon structure and one serving as a control group (PBS).
TABLE 1. MR Protocol (3 T, SkyraFit)
Parameters Morphologic T1-Mapping T2*-Mapping
Sequence T1w-TSE STIR T2w-TSE Variable Flip Angle GRE Multiecho GRE
Dimensions 2 2 3 3
Voxel dimensions, mm3 0.5  0.5  3 0.5  0.9  3 0.8  0.8  0.8 1  1  1
Repetition time, ms 680 4500 15 32
Echo time, ms 11 44 1.8 1, 2, 3,…, 20
Flip angle, degrees 90 90 6, 19, 33 8
Bandwith, Hz/Pixel 255 245 430 320
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force was recorded. Measurement of tendon stress at small strain levels
(≤5% strain) allows to obtain mechanical data of differently treated ten-
dons while keeping the microstructure of the tendon intact. For stress
calculation, the cross-sectional area of the tendon specimen was
scanned in triplicate using a custom made linear laser measurement de-
vice (accuracy, −3.52% ± 1.89%; precision, 0.83%).24,25
Histopathology and Immunohistology of Tendons
In experiment II, tendons used for histopathology analysis were
cut in 3 pieces. The distal and medial (middle) portionswere then stored
in CryoTubes and filled with formaldehyde solution 4%, ph 7, buffered
(Roti-Histofix, Carl Roth GmbH, Germany).
After fixation, the tendons were cut into a longitudinal and 2
cross-sections before they were routinely embedded into paraffin. Cut
sections of 2- to 3-μm thickness were afterward sectioned and stained
with hematoxylin and eosin. Unstained paraffin-embedded tendon sec-
tions were deparaffinized and the antigen demasked by boiling the slides
in a pressure cooker (Pascal, DakoCytomation) at 80°C in a basic buffer.
Afterward, the tendons were incubated for 1 hour at 37°C with the poly-
clonal rabbit anti-collagen I antibody (Abcam Ab34710) at a dilution of
1:100. As secondary antibody, the Red Map Kit (760–4154 Roche [rab-
bit/mouse]) was used and then the slides evaluated by light microscopy.
Collagen cross-linking was verified by making use of its distinct
optical spectral properties. Genipin cross-links emit fluorescence at a
peak wavelength of 630 nm when excited at 590 nm.26,27 Microscopy
imaging was performed using an inverted spinning disc confocal micro-
scope (iMic; FEI Munich GmbH, Hillsboro, OR) with a 4x N.A. 0.16
objective (Olympus UPlanSApo) and a Hamamatsu Orca-flash 4.0 Dig-
ital CMOS camera (C11440-22CU). A collagen exciting wavelength of
405 nm22 and a genipin-specific wavelength of 560 nm were used for
visualization. Histological tendon sections of the control (PBS) as well
as CXL treatment group were mounted on a microscope slice and the
unstained slides imaged at one z-plane. Image analysis was done in
ImageJ (NIH Image). The ratio of mean pixel intensity between both
excitation wavelengths was subsequently compared between PBS and
CXL sections using Student t test (n = 6).
Statistical Analysis of T1 and T2* Maps
The data were descriptively reviewed and statistically tested for
normality with the Kolmogorov-Smirnov test. All results were expressed
as means ± standard deviations. For quantitative analysis, Student t test
for not related samples was used to test for significant differences be-
tween different groups of tendon preparation. Fisher exact test was used
for qualitative visual data analysis, whereas Mann-Whitney U test was
used to evaluate significant differences of tendon quality. P values less
than 0.05 were considered statistically significant. All statistical analyses
were performed using commercially available software (SPSS, release
20.0, Chicago, IL).
RESULTS
Quantitative Analysis and Percentage Difference
in Signal (Pre vs Post)
There was a significant difference of T1 and T2* times between
untreated and treated tendons in total (both, P < 0.001) and for each
group of treatment (COL/CXL/PBS) separately (all, P < 0.04, data
not shown). Overall, there was an increase in T1 and T2* relaxation
times for each group after incubation, whereas the COL group (porosity
increasing) showed almost 200% increase of percentage difference
(ΔT1 median, 188%; ΔT2* median, 195%).
However, ΔT1 and ΔT2* showed only significant differences
between collagenase-treated tendons and both cross-linked and control
tendons but not between cross-linked and control tendons (P > 0.9,
P = 0.051; Fig. 4).
FIGURE 3. Before (A) and after 24 hours (B) of incubation of treated tendons. Image C shows a standard T2-weighted sequence-slice of the posttreated
phantom. D, Side view with indicated axial plane (blue plane). E, Visual example of T1 color map for data read out in axial orientation.
FIGURE 4. Relative difference in T1 and T2* relaxation times of untreated
and treated groups: collagenase (COL), collagen cross-linked (CXL) and
control (PBS). Boxplots with median and whiskers from minimum to
maximum, level of significance is defined as follows: *P < 0.05. ΔT1,
T2* = (treated − untreated/untreated).
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After Treatment
For T1-mapping (T1_treated), there was a significant difference
between COL-treated tendons (median, 1384 milliseconds) showing al-
most one third higher T1-relaxation times and both CXL-treated (median,
890 milliseconds) and control tendons (PBS; median, 942 milliseconds;
all, P < 0.01), whereas no significant difference was seen between
CXL and PBS-treated tendons (T1 post, P > 0.3).
T2* mapping (T2*_treated) revealed significant differences between
COL (median, 5.35milliseconds) and bothCXL (median, 3.44millisec-
onds) and PBS (median, 2.10; both, P < 0.01), as well as between CXL
and PBS groups (Fig. 5).
Reproducibility and Repeatability of the Setup
No significant differences of T1 and T2* times were seen be-
tween scans of experiment I and experiment II of untreated tendons
(both, P > 0.45; Fig. 6). For treated tendons, no significant differences
of T1 and T2* times were seen between repetitive T1 and T2* scans of
experiment II (both, P > 0.5).
Results Biomechanics
Before incubation, there was no significant correlation between
tendon stress at 5% strain and T2* relaxation time (P = 0.22) with an
overall mean value of 13.14 ± 5.6 MPa at 5% strain. However, after
treatment of tendons, a significant linear regression emerged
(r = −0.74, P < 0.01), indicating that treatment agents effected tendon
mechanics respective their collagen structure (Fig. 7). Both treatment
groups COL and CXL showed a decrease in stress (−49%, −14%) at
5% strain, compared with the control group (PBS). Mean stress values
for COL-, CXL-, and PBS-treated tendons at 5% strain were 5.0 ± 2.3,
8.5 ± 3.0, and 10.1 ± 3.0 MPa, respectively. For T1-mapping, no signif-
icant correlation was seen (data not shown).
Qualitative Analysis by Qualitative, Standard Clinical
Analysis of MRI
Both readers clearly identified all COL-treated samples as show-
ing visually detectable degenerative changes (grade II 8/8). In the CXL
group, no degenerative changes were noted for both readers, but one
tendon demonstrated a visible edema associated with the bolus injection
for reader 1 (grade 0, 7/8; grade I, 1/8), whereas reader 2 detected 2
CXL-treated tendons with increased signal on STIR imaging (grade
0, 6/8; grade I, 2/8). Similarly, in the PBS group, no degenerative
changes were detected, but 2 tendons were identified with visibly in-
creased water content by reader 1 (grade 0, 6/8; grade I, 2/8), whereas
3 tendons were identified by reader 2 (grade 0, 5/8; grade I, 3/8). Thus,
no significant differences in visual evaluation of the CXL and PBS
groups were detectable by standard evaluation of the MRI scans for
both readers (both, P < 0.001).
Results Histopathology and Immunohistology
Visual inspection of CXL-treated tendon samples before histol-
ogy showed a bluish change in color, whereas COL-treated samples
seemed to look more aqueous.
In the tendons treated by collagenase, hematoxylin and eosin
staining indicated revealed rounding of cell nuclei, ruptured collagen
FIGURE 5. T1 and T2* relaxation times of treated groups: collagenase (COL), collagen cross-linked (CXL), and control (PBS). Boxplots with median and
whiskers from minimum to maximum, level of significance is defined as follows: *P < 0.05.
FIGURE 6. Reproducibility of the measurement setup between 4 weeks of experiment 1 and 2 (T1, T2* relaxation times of each 12 tendon specimen
before treatment). Boxplots with median and whiskers from minimum to maximum, level of significance is defined as follows: *P < 0.05.
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fibers, and loss of staining intensity (Fig. 8). Collagen I immunohistology
also showed less intense staining in the degenerating regions of the
collagenase-treated tendons. In contrast, cross-linked tendons showed no ob-
servable histological abnormalities or regional variations in collagen staining.
Successful collagen cross-linking by the injected genipin solu-
tion was indicated by a measured significant differences in tissue auto-
fluorescence at genipin-specific excitations (Fig. 9).
DISCUSSION
In this study, we implemented a reproducible tissue-based MRI
phantom model to test the potential of T1- and T2*-mapping for quan-
tification of biophysical differences in tendon structure and function in-
duced by a range of chemical treatments.3,28–31 Treated tendons were
referenced against benchtop measures of tissue biomechanics and tis-
sue histology. Our results indicated that T1-mapping and T2*-mapping
were both capable of detecting collagenase-induced tendon degenera-
tion that resembled advanced stage tendinopathy collagen distortion.
Subtle changes with increased tendon cross-linking, however, could
be successfully detected using T2*-mapping with short echo times. In-
terestingly, biomechanical testing correlated exclusively and negatively
with T2*-mapping as T2* times and extracellular water content de-
crease when tendon stress exertion increases.
Conventional MRI shows a limited diagnostic capability for chronic
tendinopathy due to intermediate to long echo-times (20–60 milliseconds)
of standard spin and gradient echo sequences, which are substantially
longer than the intrinsic T2 and T2* values of tendons, which are in
the order of a few milliseconds.32 For this specific application, recently
introduced ultrashort echo-times imaging, however, was shown to over-
come the limitations of standard sequences allowing visualization and
quantification of pathological changes in the human Achilles tendon.33
For T2*-mapping, a 2-component model reflective of short and long
echo-times was proposed. The short component of T2* decay, which
is related to bound water of collagen, GAG, and other proteins, allows
best for discrimination of healthy from diseased tendons, suggesting
that it reflects the changes in water content and collagen orientation more
accurately than the long component of T2* decay or T1-mapping, which
are related to free water of the interstitial space.34
Several studies have been performed assessing relaxation times
of healthy and degenerated tendons in vivo and in vitro using T2* with
short echo-times.9,13,33,35–40 Our results in healthy bovine tendons are
comparable to T1 and T2* values of a recent ex vivo34 and in vivo stud-
ies,33,36 with T2* values ranging from 0.92 to 2.72 milliseconds and T1
values ranging from 311 to 733 milliseconds.
There are many factors that can affect T1 and T2/T2* measure-
ments. Although saline solution is recommended to prevent specimen
FIGURE 7. T2* stress relaxation and correlation of tendon stress at 5% strain. Black dotted lines indicate the 95% confidence intervals. Left, nonsignificant
correlation before treatment. Right, Linear regression of T2* times of treated tendons with relaxation times of treated tendons (P < 0.01) and a
correlation cofficient of r = −0.74.
FIGURE 8. Left, hematoxylin and eosin (arrow, degenerating nuclei; asterix, degenerating collagen fibers); on the right and upper side, the collagen fibers
are histologically normal. Right, immunohistology collagen I; on the left side, the degenerating collagen fibers show lesser intensity of staining for
collagen I compared with the fibers on the right side without histological degeneration signs.
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dehydration36 and to minimize susceptibility effects, a study by Zheng
and Xia35 reports that saline and PBS solution have different effects on
outcome of T2/T2* values. Moreover, T2/T2* times of water nuclei of
tendon tissue is dependent on temperature and the orientation of the tis-
sue relative to the static magnetic field B0.41–44 Assuming sufficient
signal-to-noise ratio, the orientation of the tendons with respect to the
main magnetic field does not influence the T1 maps. However, the ef-
fective transversal relaxation time T2* depends on the spatial orienta-
tion of the tendons with respect to the main magnetic field due to
dipolar interactions. Accordingly, we kept temperature and orientation
(fiber alignment) of tendons constant (perpendicular to B0) and only
immersed tendons in PBS during scanning of samples.
Spatial resolution was adapted to the size of the tendons used in
our study and the size of the clamping device. Depending on available
signal-to-noise ratio and measurement time, higher spatial resolutions
are possible, which could be useful in assessment of smaller tendons.
The influence of magic-angle effects requires further investiga-
tion, as do effects associated with imaging tendons of larger and
smaller diameter.
In our study, we aimed to evaluate the effect of change in collagen
structure on relaxation times in a controlled phantom setting.We chose to
investigate alterations to the tendon core collagen structures that are likely
to be most reliably discernable by MRI (as opposed to thin structures
such as the peritenon).18 Tendon aging, which refers to the “first” step
of tendon degeneration, is characterized by an increase of intercollagen
cross-links, aswell as increased presence of proteoglycans and other mac-
romolecules.3 Accordingly, in this “early” stage of tendon degeneration,
collagen orientation andwater content changes, whereas the tendon struc-
ture remains intact. In later stages of tendon degeneration, microtears and
degradation can result in collagen distortion with areas of mucoid or fatty
degeneration in tendon tissue.3 Genipin is a chemical agent, which was
shown to induce collagen cross-linking in previous in vitro studies,3,25,45
serving as a general model of collagen cross-linking and biophysical ef-
fects associated with decreased porosity and decreased mobility of water
within the tissue. The effect of tendon treatment with genipin was visible
by a slight blueish coloring of the tendons and confirmed by confocal mi-
croscopy serving as the reference standard for increased cross-linking. In
comparison, severe tendon degeneration as induced by collagenase
showed collagen degradation with increased tissue porosity as assessed
using histopathological and biomechanical analysis, respectively. Al-
though the simplified models of degeneration and cross-linking are both
nonphysiological, they mimic biophysical changes in tissue structure and
function that are hallmarks of disease. Further, they are reproducible, and
thus well suited for pilot testing of new radiological test phantoms
and methods.3,23,25,45,46
When comparing healthy and severely degenerated tendons,
several in vivo studies have reported a significant increase in T2 and
T2* in degenerative tendon tissue.47–49 This is consistent with our
results showing a significant increase of both T1 (+188%) and T2*
(+195%) values in higher degree of tendon degeneration with chem-
ically (collagenase) induced collagen distortion. When comparing
healthy and tendons with increased cross-linking, our results showed
significantly longer T2* times (+86%) of those functionally modified
tendons, whereas T1-mapping and visual analysis failed to distinguish
both groups. A noticeable small range of T1 values was observed for
the CXL-treated tendons. We hypothesize, as T1 is assumed to reflect
(only) the extracellular fluid, which decreases after treatment by CXL,
that T1 values decrease compared with the control group and conse-
quently are narrower in range. However, differences were not signifi-
cant to the control group, which indicated increased presence of
extracellular fluid.
The present quantitative and highly controlled work tend to sup-
port previous in vivo studies, such as those showing that T2* relaxation
times in healthy runners are significantly longer when compared with a
normal population (mean percentage increase, 15.7% ± 4.9%),33 which
might be as well explained by an adaption of the tendon matrix (cross-
linking) and consecutive changes in the free and/or bound water frac-
tions without patients being symptomatic.
Biomechanical testing correlated exclusively and negatively
with T2*-mapping. Accordingly, T2* times increasewhen tendon stress
decreases, which might reflect the increase of extracellular water frac-
tion from cross-linked tendons to collagenase-treated tendons.
Several limitations need to be acknowledged. First, tendons and
ligament properties are highly complex, and effects that lead to patho-
logical changes are manifold.50 In this study, we investigated distinct
biophysical changes to the collagen matrix in a controlled phantom
and attempted to correlate MRI metrics to histopathological and biome-
chanical metrics. Although chemical treatments used in this study are
both nonphysiological, they are among the best-establishedmeans of al-
tering mechanical properties and useful for locally altering tissue func-
tion of a phantom in a controlled and reproducible manner.3,23,25,45,46
Moreover, we did only perform T1- and T2*-mapping using a 3 T sys-
tem. However, in this pilot study, we aimed to establish a phantom
model of collagen degradation allowing for standardized ex vivo evalu-
ation of tendon biomechanics and MRI properties. Finally, the experi-
mental setup was reproducible between scans (experiments I and II)
FIGURE 9. Left, Mean image intensity at 405 and 560 nm wavelength of 6 untreated (PBS) and 6 cross-linked (CXL) tissue sections (error bar, ± SD).
Right, Confocal images of untreated (left row) and cross-linked (right row) tendon sections. Genipin cross-linked samples show increased fluorescence
at 560 nm (lower row), whereas untreated samples show a reduction in fluorescence intensity. All images are displayed at equivalent brightness scale.
White respective black bar indicate a length of 500 μm.
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of untreated tendons and test-retest reliability (experiment II), proving a
standardized workflow and reliable setup. However, to improveworkflow
and optimize a standardized treatment, tendon incubation in a water bath
should be considered, to equally effect tendons, which might be more
consistent compared with the needle injection applied in this study. Inves-
tigation of larger diameter tendons like the humanAchilles (60mm2 at its
smallest cross section, 120 mm2 at its largest)51 should be considered for
future experiments. However, the authors assume that if biophysical prop-
erties are detectable in smaller tendons, they should be even more likely
to be reliably quantified in larger diameter tendons.
CONCLUSIONS
A tendon model within a novel, highly controlled setup was
successfully introduced in MRI testing environment. Optimized T2*-map-
ping was inversely and significantly correlated to mechanical function in a
range of in vitro experiments on tendons treated by compounds that affect
their structure and function. T2*may offer increased potential to detect and
quantify early functional changes in collagen structure as it is present in
early tendon degeneration before they arevisible in standard T1MRI scans.
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